Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy
about
Assessment of in vivo and in vitro genotoxicity of glibenclamide in eukaryotic cellsLow Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging?An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer.Phyllanthus emblica Linn. fruit extract potentiates the anticancer efficacy of mitomycin C and cisplatin and reduces their genotoxicity to normal cells in vitro.Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk+/- cells and the CD90.2 antigen.Enhancer dysfunction in leukemia.Potential Benefits of Annona muricata in Combating Cancer: A Review.Genoprotective effects of gallic acid against cisplatin induced genotoxicity in bone marrow cells of mice
P2860
Q28544944-55B56B06-3AD2-4E93-AE76-F0D4C808EF2EQ37475612-1EBDFDDA-B3D8-4907-89B4-4F53B808E3D0Q38792860-2D1896E5-C903-4CE7-B76C-44E6B62F197BQ40259652-D086C339-99F4-4A76-A556-5239E2E9875EQ47284400-0F59930D-AEC9-4FC3-A1E8-0179CB2FC4EBQ47427835-B08ED310-1D0E-442C-946B-71C0E053AF3EQ50028355-DD2A67B8-EC21-4FF4-8E2C-770234D01141Q55005473-480E9152-F64B-4EBA-9B6F-54D5E9BD4BA9Q57496938-7D902833-0AD0-4C18-A484-0B4E9F392F1D
P2860
Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Persistence of cisplatin-induc ...... er risk following chemotherapy
@ast
Persistence of cisplatin-induc ...... er risk following chemotherapy
@en
Persistence of cisplatin-induc ...... er risk following chemotherapy
@nl
type
label
Persistence of cisplatin-induc ...... er risk following chemotherapy
@ast
Persistence of cisplatin-induc ...... er risk following chemotherapy
@en
Persistence of cisplatin-induc ...... er risk following chemotherapy
@nl
prefLabel
Persistence of cisplatin-induc ...... er risk following chemotherapy
@ast
Persistence of cisplatin-induc ...... er risk following chemotherapy
@en
Persistence of cisplatin-induc ...... er risk following chemotherapy
@nl
P2093
P2860
P356
P1476
Persistence of cisplatin-induc ...... er risk following chemotherapy
@en
P2093
Carson Labash
Dorothea K Torous
James Palis
James T MacGregor
Jared Mereness
Jeffrey C Bemis
John Cottom
Kristine Carlson
Souk Phonethepswath
Stephen D Dertinger
P2860
P304
P356
10.1093/TOXSCI/KFU078
P577
2014-05-05T00:00:00Z